Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 274687, 4 pages
http://dx.doi.org/10.1155/2013/274687
Conference Paper

Hyperthermia versus Oncothermia: Cellular Effects in Cancer Therapy

1Department of Physiology, University of Debrecen, Debrecen 4012, Hungary
2Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest 1094, Hungary
3Department of Complementary and Alternative Medicine, University of Pécs, Pécs 7622, Hungary
4Department of Biotechnics, St. Istvan University, Gödöllő 2103, Hungary

Received 14 January 2013; Accepted 29 April 2013

Academic Editors: G. F. Baronzio, M. Jackson, and A. Szasz

This Conference Paper is based on a presentation given by Gyula P. Szigeti at “Conference of the International Clinical Hyperthermia Society 2012” held from 12 October 2012 to 14 October 2012 in Budapest, Hungary.

Copyright © 2013 Gyula P. Szigeti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Hyperthermia means overheating of the living object completely or partly. Hyperthermia, the procedure of raising the temperature of a part of or the whole body above the normal for a defined period of time, is applied alone or as an adjunctive with various established cancer treatment modalities such as radiotherapy and chemotherapy. The fact that is the hyperthermia is not generally accepted as conventional therapy. The problem is its controversial performance. The controversy is originated from the complications of the deep heating and the focusing of the heat effect. The idea of oncothermia solves the selective deep action on nearly cellular resolution. We would like to demonstrate the force and perspectives of oncothermia as a highly specialized hyperthermia in clinical oncology. Our aim is to prove the ability of oncothermia to be a candidate to become a widely accepted modality of the standard cancer care. We would like to show the proofs and the challenges of the hyperthermia and oncothermia applications to provide the presently available data and summarize the knowledge in the topic. Like many early-stage therapies, oncothermia lacks adequate treatment experience and long-range, comprehensive statistics that can help us optimize its use for all indications.